News | Artificial Intelligence | October 24, 2019

Medical AI software company and U.S. cancer center operator partner to further advance early detection and characterization of various cancers with artificial intelligence

Enlitic Announces Strategic Partnership With Select Healthcare Solutions

October 24, 2019 — Artificial intelligence (AI) software developer Enlitic Inc. announced it has signed a strategic partnership with Select HealthCare Solutions, a developer, owner and operator of cancer centers across the U.S. As part of the agreement, Enlitic will receive access to Select Healthcare’s high-quality, anonymized patient data –– data that will further tune Enlitic’s predictive models for early cancer detection. In turn, Select HealthCare will receive access to Enlitic’s AI software technology and will directly contribute to the development of future Enlitic products in radiology, oncology and pathology.

Enlitic’s deep learning models have demonstrated potential for the early detection of malignancies. In an independent validation study from 2017, Enlitic's algorithm was found to detect lung nodules with 91.1 percent sensitivity at time of biopsy, operating on par with state-of-the-art computer-aided detection (CAD), but with much higher specificity. Furthermore, the algorithm was shown to detect malignancies 6 and 12 months before biopsy, and reliably caught cancerous nodules 17.5 months earlier than when a biopsy was ordered.

Enlitic’s partnership with Select HealthCare adds to Enlitic’s global partnership roster of healthcare and technology companies, including Capitol Health, a leading Australian healthcare provider; Marubeni Corp., a Japan-based global conglomerate; and Konica Minolta, a multinational technology company also based in Japan.

“Enlitic’s diagnostic AI software is crucial to improving patient care in the future and we are excited to join the company’s list of world-class partners by providing comprehensive multimodal data that will help revolutionize how cancer is detected and treated,” said Matthew Cutler, president and CEO of Select HealthCare Solutions. “We believe that our clinical experience in treating complex cancers, combined with Enlitic’s best-in-class technologies and experience in early disease detection, will ultimately help save millions of lives.”

For more information: www.enlitic.com


Related Content

News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

April 27 2026 — SimonMed, one of the nation’s largest independent outpatient imaging providers, has announced the ...

Time May 04, 2026
arrow
News | Radiation Oncology

April 27, 2026 — Radiation oncologists from across the country were in Washington in late April to warn lawmakers that ...

Time May 04, 2026
arrow
News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Artificial Intelligence

April 20, 2026 — DeepTek, provider of the Augmento platform and deepc, the company behind deepcOS, have introduced a ...

Time April 23, 2026
arrow
News | Computed Tomography (CT)

April 2, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for True ...

Time April 03, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
News | Computed Tomography (CT)

March 30, 2026 — HCA Healthcare’s Good Samaritan Hospital is the first hospital in the Bay Area to implement Lumina 3D ...

Time April 01, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
Subscribe Now